Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Stabilized Cyclic Peptides as Scavengers of Autoantibodies: Neutralization of Anticitrullinated Protein/Peptide Antibodies in Rheumatoid Arthritis.

Gunasekera S, Fernandes-Cerqueira C, Wennmalm S, Wähämaa H, Sommarin Y, Catrina AI, Jakobsson PJ, Göransson U.

ACS Chem Biol. 2018 Jun 15;13(6):1525-1535. doi: 10.1021/acschembio.8b00118. Epub 2018 May 24.

PMID:
29630823
2.

Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis.

Carmona-Rivera C, Carlucci PM, Moore E, Lingampalli N, Uchtenhagen H, James E, Liu Y, Bicker KL, Wahamaa H, Hoffmann V, Catrina AI, Thompson P, Buckner JH, Robinson WH, Fox DA, Kaplan MJ.

Sci Immunol. 2017 Apr;2(10). pii: eaag3358. doi: 10.1126/sciimmunol.aag3358. Epub 2017 Apr 14.

3.

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.

Krishnamurthy A, Joshua V, Haj Hensvold A, Jin T, Sun M, Vivar N, Ytterberg AJ, Engström M, Fernandes-Cerqueira C, Amara K, Magnusson M, Wigerblad G, Kato J, Jiménez-Andrade JM, Tyson K, Rapecki S, Lundberg K, Catrina SB, Jakobsson PJ, Svensson C, Malmström V, Klareskog L, Wähämaa H, Catrina AI.

Ann Rheum Dis. 2016 Apr;75(4):721-9. doi: 10.1136/annrheumdis-2015-208093. Epub 2015 Nov 26.

4.

JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation.

Lu B, Antoine DJ, Kwan K, Lundbäck P, Wähämaa H, Schierbeck H, Robinson M, Van Zoelen MA, Yang H, Li J, Erlandsson-Harris H, Chavan SS, Wang H, Andersson U, Tracey KJ.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3068-73. doi: 10.1073/pnas.1316925111. Epub 2014 Jan 27.

5.

IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts.

Leclerc P, Wähämaa H, Idborg H, Jakobsson PJ, Harris HE, Korotkova M.

Scand J Immunol. 2013 May;77(5):350-60. doi: 10.1111/sji.12041.

6.

High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.

Wähämaa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger AC, Andersson U, Harris HE.

Arthritis Res Ther. 2011 Aug 26;13(4):R136. doi: 10.1186/ar3450.

7.

Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.

Schierbeck H, Wähämaa H, Andersson U, Harris HE.

Mol Med. 2010 Sep-Oct;16(9-10):343-51. doi: 10.2119/molmed.2010.00031. Epub 2010 Apr 9.

8.

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE.

J Leukoc Biol. 2009 Sep;86(3):655-62. doi: 10.1189/jlb.0908548. Epub 2009 Jun 29.

PMID:
19564572
9.

Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis.

Ostberg T, Wähämaa H, Palmblad K, Ito N, Stridh P, Shoshan M, Lotze MT, Harris HE, Andersson U.

Arthritis Res Ther. 2008;10(1):R1. doi: 10.1186/ar2347. Epub 2008 Jan 7.

10.

Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate.

Zetterström CK, Jiang W, Wähämaa H, Ostberg T, Aveberger AC, Schierbeck H, Lotze MT, Andersson U, Pisetsky DS, Erlandsson Harris H.

J Leukoc Biol. 2008 Jan;83(1):31-8. Epub 2007 Oct 3.

PMID:
17913975
11.

The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta.

Holmlund U, Wähämaa H, Bachmayer N, Bremme K, Sverremark-Ekström E, Palmblad K.

Immunology. 2007 Nov;122(3):430-7. Epub 2007 Jul 6.

12.

HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay.

Wähämaa H, Vallerskog T, Qin S, Lunderius C, LaRosa G, Andersson U, Harris HE.

J Leukoc Biol. 2007 Jan;81(1):129-36. Epub 2006 Sep 15.

PMID:
16980509

Supplemental Content

Loading ...
Support Center